We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Hikma Pharmaceuticals Plc | HIK | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 64.00 | 3.45% | 1,918.00 | 16:29:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1,861.00 | 1,861.00 | 1,920.00 | 1,854.00 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 22/02/2024 | Final | USD | 0.47 | 21/03/2024 | 22/03/2024 | 03/05/2024 |
| 03/08/2023 | Interim | USD | 0.25 | 10/08/2023 | 11/08/2023 | 15/09/2023 |
| 23/02/2023 | Final | USD | 0.37 | 23/03/2023 | 24/03/2023 | 05/05/2023 |
| 04/08/2022 | Interim | USD | 0.19 | 18/08/2022 | 19/08/2022 | 20/09/2022 |
| 24/02/2022 | Final | GBP | 0.276476 | 17/03/2022 | 18/03/2022 | 28/04/2022 |
| 06/08/2021 | Interim | USD | 0.18 | 19/08/2021 | 20/08/2021 | 20/09/2021 |
| 25/02/2021 | Final | USD | 0.34 | 18/03/2021 | 19/03/2021 | 26/04/2021 |
| 07/08/2020 | Interim | USD | 0.16 | 20/08/2020 | 21/08/2020 | 21/09/2020 |
| 27/02/2020 | Final | GBP | 0.242169 | 19/03/2020 | 20/03/2020 | 07/05/2020 |
| 09/05/2019 | Interim | USD | 0.14 | 22/08/2019 | 23/08/2019 | 23/09/2019 |
| Interim | USD | 0.14 | 21/08/2019 | 23/08/2019 | 23/09/2019 |
| Top Posts |
|---|
Posted at 22/2/2024 07:06 by robertball Dividend hike is chunky |
Posted at 13/1/2024 21:31 by hopeful holder So far, HIK has proven to be better even over this short period. |
Posted at 02/3/2023 17:11 by waldron LOOKING TOPPYNOT IMPRESSED WITH DIVI Having said that if results good, might move up 20pc if EV anything to go by |
Posted at 30/9/2022 10:32 by cumnor Bought in here at £13 avg. Now the diversity nonsense is out of the way these guys (and gals I suppose) need to up the ante on their dividend payments if they wish to recover the share price..... |
Posted at 15/9/2022 12:01 by swinsco Jeffries have just cut Hik price target to 2020 from 2200 and keep it a buy rating. Broker nonsense! |
Posted at 07/9/2022 08:19 by blue59 But don’t forget the ever increasing dividend. So that’s a 51% loss in capital value to earn 2% in the last year, great way to lose your wealth! |
Posted at 01/9/2022 11:56 by mjneish Good to see HIK outperforming the wider market at the moment. FTSE down 1.5% at the moment, and HIK down only 1%. :) |
Posted at 26/8/2022 17:49 by mjneish I've run a Piotroski F-score on HIK and got a score of 7 out of 9 (scores of 8 or 9 are considered good). They narrowly miss out on a score of 8 by a fraction of a percent.This is using the previous two years' final results, and so before the erosion of their generics business really started to bite. Having never done an F-score before, I'd be happy to share details of the calculation just in case someone who knows about it can confirm that it's been correctly done. It will be quite long-winded. |
Posted at 18/8/2022 20:32 by cumnor Punters and IIs are tiring of indebted companies like Hikma which paid divis of 2% for past couple of years, promised the earth and fail to deliver, as recent results show. Meanwhile directors pay themselves huge salaries and bonuses but expect investors to pay dear for the measly dividend. This could have been more generous and the recent falls (not just here) in poor payers share prices reflect a change in attitude to greedy directors.Needs to see a divi of 5% plus before I'd touch this. |
Posted at 04/4/2022 10:35 by netcurtains blue: That is the point, asuming there is nothing fundamentally wrong with HIK, it does appear to be quite cheap.HIK Pe 15 GSK Pe 19 AZN Pe (dont totally nuts). Of the three, if nothing wrong with HIK, then HIK is probably looking pretty good. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
